132 related articles for article (PubMed ID: 10516413)
1. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure.
Dasbach EJ; Rich MW; Segal R; Gerth WC; Carides GW; Cook JR; Murray JF; Snavely DB; Pitt B
Cardiology; 1999; 91(3):189-94. PubMed ID: 10516413
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Pitt B; Poole-Wilson P; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
[TBL] [Abstract][Full Text] [Related]
3. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
7. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
Cowley AJ; Wiens BL; Segal R; Rich MW; Santanello NC; Dasbach EJ; Pitt B;
Qual Life Res; 2000; 9(4):377-84. PubMed ID: 11131930
[TBL] [Abstract][Full Text] [Related]
9. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Reed SD; Radeva JI; Weinfurt KP; McMurray JJ; Pfeffer MA; Velazquez EJ; Allsbrook JS; Masselink LE; Sellers MA; Califf RM; Schulman KA;
Am Heart J; 2005 Aug; 150(2):323-9. PubMed ID: 16086938
[TBL] [Abstract][Full Text] [Related]
10. [Cost effectiveness of captopril after myocardial infarct; comment].
Szucs T; Berger K; Schulte-Hillen J; Kleber FX
Med Klin (Munich); 1996 Feb; 91(2):112-8. PubMed ID: 8850108
[TBL] [Abstract][Full Text] [Related]
11. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
12. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
Arredondo A; Burke TA; Carides GW; Lemus E; Querol J
Rev Invest Clin; 2005; 57(3):399-405. PubMed ID: 16187699
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group
BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
[TBL] [Abstract][Full Text] [Related]
15. [The ELITE 2 study].
Mahé I
Presse Med; 2000 Sep; 29(25):1407. PubMed ID: 11036516
[No Abstract] [Full Text] [Related]
16. [A-II blocker or ACE inhibitor in heart failure? Captopril can't be beat].
Einecke D
MMW Fortschr Med; 1999 Nov; 141(47):4-5. PubMed ID: 10912155
[No Abstract] [Full Text] [Related]
17. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
[TBL] [Abstract][Full Text] [Related]
18. Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure?
Trojian TH; Jackson EA
J Fam Pract; 2000 Aug; 49(8):759-60. PubMed ID: 10947144
[No Abstract] [Full Text] [Related]
19. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ
Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875
[TBL] [Abstract][Full Text] [Related]
20. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
Pitt B
MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
